Danaher Co. (NYSE:DHR) Shares Sold by Adalta Capital Management LLC

Adalta Capital Management LLC lessened its holdings in shares of Danaher Co. (NYSE:DHR) by 19.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,857 shares of the conglomerate’s stock after selling 1,610 shares during the quarter. Danaher makes up about 0.8% of Adalta Capital Management LLC’s portfolio, making the stock its 25th biggest holding. Adalta Capital Management LLC’s holdings in Danaher were worth $1,576,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the business. Heck Capital Advisors LLC acquired a new position in Danaher in the 4th quarter valued at about $27,000. Golden State Wealth Management LLC acquired a new position in Danaher in the fourth quarter valued at approximately $31,000. Strategic Financial Concepts LLC acquired a new position in Danaher in the fourth quarter valued at approximately $31,000. Pineridge Advisors LLC grew its position in Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 57 shares during the period. Finally, Kentucky Trust Co acquired a new stake in Danaher during the fourth quarter worth $34,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

DHR has been the subject of a number of research analyst reports. Raymond James reiterated a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. Citigroup reaffirmed a “buy” rating on shares of Danaher in a research report on Monday, April 7th. Guggenheim reiterated a “buy” rating and set a $250.00 price target on shares of Danaher in a research report on Wednesday, April 23rd. JPMorgan Chase & Co. decreased their price objective on shares of Danaher from $280.00 to $260.00 and set an “overweight” rating on the stock in a report on Tuesday, April 22nd. Finally, Robert W. Baird decreased their price target on Danaher from $231.00 to $225.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. Four analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $263.24.

Danaher Trading Up 0.6%

NYSE DHR opened at $197.68 on Wednesday. Danaher Co. has a 52 week low of $171.00 and a 52 week high of $281.70. The firm has a 50 day moving average of $196.56 and a two-hundred day moving average of $216.78. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The stock has a market capitalization of $141.47 billion, a PE ratio of 37.44, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. The business had revenue of $5.74 billion during the quarter, compared to analysts’ expectations of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. As a group, research analysts expect that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.65%. Danaher’s payout ratio is currently 24.85%.

Insider Activity

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the firm’s stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman now owns 3,105,808 shares of the company’s stock, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the sale, the executive vice president now owns 15,179 shares in the company, valued at $3,005,442. This trade represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.